HealthTree Logo
search more_vert
close
person Sign In / Create Account

Clinical Expertise

Dr. McCloskey's research focus is on phase I/II non-randomized study of birinapant in combination with decitabine in patients with relapsed or refractory myelodysplastic syndrome and acute myelogenous leukemia, and was a primary investigator of cellular and molecular characterization of the immune response and minimal residual disease in patients who have completed treatment for acute myeloid leukemia.

Location

Hackensack - John Theurer Cancer Center : 30 Prospect Ave, Hackensack, NJ 07601, USA

Get the latest thought leadership on Acute Myeloid Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Acute Myeloid Leukemia Newsletter" for Acute Myeloid Leukemia news, life with Acute Myeloid Leukemia stories, Acute Myeloid Leukemia clinical trials, Acute Myeloid Leukemia 101 articles and events with Acute Myeloid Leukemia experts.

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Abbvie
Astellas Pharma
Servier

Follow Us

facebook instagram youtube